BiotechTube
Coris Bioconcept

Coris Bioconcept

Gembloux, Belgium· Est.
corisbio.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $6.5M

Overview

Coris BioConcept is a specialized diagnostics company with a 25-year history, operating from Gembloux, Belgium. It has established a niche in rapid tests for infectious diseases, particularly building a comprehensive suite of products for detecting carbapenemase and other antibiotic resistance mechanisms, which are critical in combating antimicrobial resistance (AMR). The company leverages multiple technology platforms—immunochromatography (lateral flow), electrochemistry, and RT-LAMP—to serve clinical, veterinary, and public health markets. As a private, revenue-generating SME, Coris competes by addressing specific, high-need diagnostic gaps with its portfolio of commercialized tests.

Infectious DiseaseAntimicrobial Resistance

Technology Platform

Multi-platform diagnostics company utilizing Immunochromatography (Lateral Flow), Electrochemistry for beta-lactamase detection, and RT-LAMP for isothermal nucleic acid amplification.

Funding History

2
Total raised:$6.5M
Series A$5M
Grant$1.5M

Opportunities

The global crisis of Antimicrobial Resistance (AMR) creates a large and growing demand for rapid diagnostics to guide antibiotic stewardship, a core strength of Coris's RESIST product line.
Additionally, the post-pandemic emphasis on decentralized, rapid testing and the expansion of molecular diagnostics (via its RT-LAMP platform) present significant market expansion opportunities.

Risk Factors

Intense competition from large, well-capitalized diagnostics corporations and other SMEs poses a constant threat to market share and pricing.
Regulatory hurdles for entering new markets (e.g., FDA clearance for the US) and dependence on the infectious disease diagnostics segment, which can be affected by epidemiological shifts, are key business risks.

Competitive Landscape

Coris competes in the crowded rapid diagnostics space against global IVD leaders like Abbott, Roche, Siemens Healthineers, and bioMérieux, as well as specialized AMR diagnostic companies like NG Biotech and Bruker. Its differentiation lies in its focused expertise on specific resistance mechanisms and its multi-technology approach, offering solutions from simple lateral flow to more complex electrochemistry and molecular (RT-LAMP) tests.

More companies in Diagnostics & Precision Medicine →More companies in Belgium →